ISRCTN93864182已完成2 期
Phase II/III study to investigate the efficacy of 5-aminolaevulinic acid (ALA)-based photodynamic therapy in the treatment of Bowen's disease, actinic keratoses and study the effect of dose fractionation for superficial basal cell carcinomas
Department of Health (UK)0 个研究点目标入组 0 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Recruited from clinical oncology consultants to whom patients are referred at a district general hospital. Also direct from consultant dermatologists/plastic surgeons in Leeds and Airedale.
排除标准
- •Does not match inclusion criteria
研究者
相似试验
进行中（未招募）
1 期
MK-5172 + MK-8742 in HCV-infected subjects with hepatic insufficiency (CP-B)MedDRA version: 18.0Level: LLTClassification code 10019751Term: Hepatitis C virusSystem Organ Class: 100000004848Hepatitis CEUCTR2014-000672-25-ITMERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC.6
进行中（未招募）
1 期
Clinical trial to evaluate the efficacy and the safety of a combination of bendamustine-melphalan as preparative regimen to autologous transplantation of hematopoietic cells for multiple myeloma who did not responded after previous high-dose therapyMultiple myelomaEUCTR2014-000130-37-ITFONDAZIONE NEOPLASIE SANGUE ONLUS (FO.NE.SA. Onlus)73
进行中（未招募）
不适用
Prospective phase II trial evaluating efficacy of Trastuzumab therapy in HER2 FISH positive and/or HER2 mutation positive, pretreated, Non-Small Cell Lung Cancer patients (MO20509) - NDEUCTR2007-003709-29-ITISTITUTO CLINICO HUMANITAS
招募中
2 期
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
进行中（未招募）
1 期
Clinical trial to evaluate the effect of vitamin D on renal progression in patients with Chronic Kidney Disease and vitamin D deficiencyEUCTR2016-002913-23-ESFundación Hospital Alcorcón170